↓ Skip to main content

Fexapotide triflutate vs oral pharmacotherapy as initial therapy for moderate-to-severe benign prostate hyperplasia patients: a cost-effectiveness analysis

Overview of attention for article published in BMC Urology, May 2022
Altmetric Badge

Mentioned by

twitter
1 X user

Readers on

mendeley
12 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Fexapotide triflutate vs oral pharmacotherapy as initial therapy for moderate-to-severe benign prostate hyperplasia patients: a cost-effectiveness analysis
Published in
BMC Urology, May 2022
DOI 10.1186/s12894-022-01025-4
Pubmed ID
Authors

Yifan Wei, Joel W. Hay, Alan R. Hay, Sze-chuan Suen

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 12 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 12 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 1 8%
Lecturer 1 8%
Student > Postgraduate 1 8%
Lecturer > Senior Lecturer 1 8%
Unknown 8 67%
Readers by discipline Count As %
Nursing and Health Professions 1 8%
Business, Management and Accounting 1 8%
Agricultural and Biological Sciences 1 8%
Medicine and Dentistry 1 8%
Unknown 8 67%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 May 2022.
All research outputs
#18,810,584
of 23,312,088 outputs
Outputs from BMC Urology
#531
of 765 outputs
Outputs of similar age
#315,826
of 442,259 outputs
Outputs of similar age from BMC Urology
#14
of 24 outputs
Altmetric has tracked 23,312,088 research outputs across all sources so far. This one is in the 11th percentile – i.e., 11% of other outputs scored the same or lower than it.
So far Altmetric has tracked 765 research outputs from this source. They receive a mean Attention Score of 5.0. This one is in the 13th percentile – i.e., 13% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 442,259 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 18th percentile – i.e., 18% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 24 others from the same source and published within six weeks on either side of this one. This one is in the 29th percentile – i.e., 29% of its contemporaries scored the same or lower than it.